CHE

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended March 31, 2004, for Roto-Rooter, Inc. (doing business as Chemed Corp). The reporting period is defined by the completion of a major strategic acquisition: on February 24, 2004, the Company acquired a controlling 63% interest in Vitas Healthcare Corporation, the nation's largest provider of hospice services, for a total purchase price of approximately $362.3 million. This transaction fundamentally altered the Company's business mix, adding a significant healthcare segment to its traditional plumbing and drain cleaning operations.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Consolidated revenues increased 69% to $131.0 million, driven almost entirely by the inclusion of Vitas Healthcare revenues ($51.1 million) for the period following the February 24 acquisition. Organic growth in the Plumbing and Drain Cleaning segment was modest (approx. 6-7%).
• Profitability Decline: The Company reported a net loss of $7.1 million compared to net income of $3.6 million in the prior year. This reversal was caused by significant one-time charges:
  • LTIP Payout: A $9.1 million pretax expense ($5.9 million after-tax) related to the Executive Long-Term Incentive Plan triggered by stock price targets.
  • Debt Extinguishment: A $3.3 million loss on the early retirement of senior debt to facilitate the Vitas acquisition.
  • Equity in Loss of Affiliate: A $4.1 million charge representing the Company's 37% share of Vitas' transaction costs incurred prior to the acquisition date.
• Balance Sheet Transformation: Total assets nearly doubled from $329.1 million to $791.7 million due to the acquisition. Goodwill increased from $105.3 million to $452.7 million. Long-term debt surged from $25.9 million to $315.8 million following the issuance of $335 million in new debt and equity to fund the deal.
• Cash Flow: Operating cash flow turned negative ($8.3 million used) compared to positive in 2003, primarily due to working capital changes and the timing of the acquisition. Investing activities consumed $316.1 million for the acquisition, offset by $316.9 million in financing proceeds.

Guidance, Outlook, and Risks

Management Commentary: Management views the Vitas acquisition as financially advantageous, citing the fragmented nature of the hospice market and Vitas' infrastructure to capitalize on growth. Vitas reported a 23% revenue increase and 24% operating profit increase in March 2004 compared to March 2003, driven by an 18% increase in average daily census.

Debt Covenants: The Company has incurred significant leverage to fund the acquisition. It must adhere to strict financial covenants starting June 30, 2004, including a maximum leverage ratio of 5.5:1 through 2004 and a minimum fixed charge coverage ratio of 1.15:1. Management currently projects compliance with these covenants.

Risks and Contingencies:

• Acquisition Integration: Final purchase price allocation is preliminary; goodwill may be adjusted if additional intangible assets are identified.
• Severance Obligations: Approximately $16.0 million in accrued severance is recorded for Vitas key employees who may exercise rights to terminate and receive two years' compensation. Three employees have already exercised this right.
• Litigation: The Company faces two class action lawsuits regarding unlicensed plumbing work and parts charges. While management believes the impact will not be material, outcomes are uncertain.
• Financing Terms: The new credit facility is subject to potential term changes by the administrative agent (Bank One) pending syndication.

Investor Verification Checklist

• Debt Covenant Compliance: Verify the Company's ability to meet the 5.5:1 leverage ratio and 1.15:1 fixed charge coverage ratio in the upcoming quarters given the high debt load.
• Vitas Integration Costs: Monitor the finalization of the purchase price allocation and the actual number of Vitas employees exercising severance rights (currently estimated at $16M liability).
• LTIP Impact: Confirm that the $9.1 million LTIP expense is a one-time event and review future compensation plan structures.
• Segment Margins: Analyze the divergence in gross margins between the high-margin Plumbing segment (44.6%) and the lower-margin Vitas segment (20.8%) to understand long-term blended profitability.
• Working Capital: Review the significant increase in accounts receivable allowances ($10.1M) and the negative operating cash flow to ensure liquidity remains sufficient for debt service.